Offstream
news

---

Changes

1. The Food and Drug Administration approves for emergency use the Sinopharm BBIBP-CorV vaccine.
   2021-06-08 05:05:40 (First version)
2. The Philippines's Food and Drug Administration approves for emergency use the Sinopharm BBIBP-CorV vaccine.
   (Current version)

---

Related

Sri Lanka receives a shipment of 300,000 doses of the Sinopharm BBIBP-CorV vaccine donated from China's People's Liberation Army.
2021-08-28

Due to public outrage, President Rodrigo Duterte apologizes for receiving a dose of the Sinopharm BBIBP-CorV COVID-19 vaccine, which has not yet been authorized by the Philippines' Food and Drug Administration for emergency use.
2021-05-6

The Indonesian Food and Drug Authority grants an emergency use authorization for the Sinopharm BBIBP-CorV vaccine, where the vaccine will be used as part of a mutual vaccination scheme.
2021-04-30

Cameroon receives 200,000 doses of the Sinovac BBIBP-CorV vaccine from China, which will be used in the first phase of their vaccination campaign.
2021-04-11

The Drug Regulatory Authority of Pakistan grants emergency use authorisation of the Sinopharm BBIBP-CorV vaccine for people over 60 years of age.
2021-03-5

Prime Minister Viktor Orbán receives the first dose of the Sinopharm BBIBP-CorV vaccine.
2021-02-28

Egypt approves the use of Sinopharm's BBIBP-CorV vaccine, with the vaccination campaign expected to start later this month. Egypt plans to buy 40 million doses of this vaccine.
2021-01-3

Bahrain's National Health Regulatory Authority approves the registration of the BBIBP-CorV vaccine developed by Sinopharm after Phase III clinical trials results showed an 86% efficacy rate.
2020-12-13

President Rodrigo Duterte issues an executive order granting the Food and Drug Administration (FDA) an emergency use authorization for COVID-19 drugs and vaccines.
2020-12-2

Pfizer and BioNTech apply for an emergency use authorization from the U.S. Food and Drug Administration for their vaccine. If the application is approved, the vaccine will likely be limited and rolled out in phases.
2020-11-20